NL7909265A - N-aryl-n'-(2-imidazolidinylideen)-ureumderivaten, alsmede farmaceutische preparaten, die deze derivaten bevatten. - Google Patents

N-aryl-n'-(2-imidazolidinylideen)-ureumderivaten, alsmede farmaceutische preparaten, die deze derivaten bevatten. Download PDF

Info

Publication number
NL7909265A
NL7909265A NL7909265A NL7909265A NL7909265A NL 7909265 A NL7909265 A NL 7909265A NL 7909265 A NL7909265 A NL 7909265A NL 7909265 A NL7909265 A NL 7909265A NL 7909265 A NL7909265 A NL 7909265A
Authority
NL
Netherlands
Prior art keywords
urea
compound
imidazolidinylidene
formula
aryl
Prior art date
Application number
NL7909265A
Other languages
English (en)
Dutch (nl)
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NL7909265A publication Critical patent/NL7909265A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7909265A 1978-12-22 1979-12-21 N-aryl-n'-(2-imidazolidinylideen)-ureumderivaten, alsmede farmaceutische preparaten, die deze derivaten bevatten. NL7909265A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms
US97257978 1978-12-22
US97258078 1978-12-22

Publications (1)

Publication Number Publication Date
NL7909265A true NL7909265A (nl) 1980-06-24

Family

ID=27130555

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7909265A NL7909265A (nl) 1978-12-22 1979-12-21 N-aryl-n'-(2-imidazolidinylideen)-ureumderivaten, alsmede farmaceutische preparaten, die deze derivaten bevatten.

Country Status (23)

Country Link
AT (1) AT373878B (fi)
AU (2) AU532332B2 (fi)
CA (1) CA1127651A (fi)
CH (1) CH647236A5 (fi)
DE (1) DE2951213A1 (fi)
DK (1) DK548179A (fi)
ES (1) ES8101558A1 (fi)
FI (1) FI66354C (fi)
FR (2) FR2444462B1 (fi)
GB (2) GB2040681B (fi)
GR (1) GR68018B (fi)
HU (1) HU183013B (fi)
IL (1) IL59019A (fi)
IT (1) IT1126839B (fi)
NL (1) NL7909265A (fi)
NO (1) NO794249L (fi)
NZ (1) NZ192453A (fi)
PH (1) PH16571A (fi)
PT (1) PT70624A (fi)
SE (1) SE7910612L (fi)
SU (1) SU971098A3 (fi)
YU (1) YU314979A (fi)
ZW (1) ZW25379A1 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200137557A1 (en) * 2018-10-29 2020-04-30 Apple Inc. Mechanism to Activate and Manage a Standalone Device for Cellular Service

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (fr) * 1960-08-05 1962-06-22 Geigy Ag J R Nouveaux composés 2-imino-1.3-di-aza et leur préparation
NL267923A (fi) * 1960-08-05

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200137557A1 (en) * 2018-10-29 2020-04-30 Apple Inc. Mechanism to Activate and Manage a Standalone Device for Cellular Service
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service
US11770695B2 (en) 2018-10-29 2023-09-26 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Also Published As

Publication number Publication date
AU5378079A (en) 1980-06-26
FR2445321B1 (fi) 1983-08-26
SU971098A3 (ru) 1982-10-30
IT7951164A0 (it) 1979-12-21
FR2444462A1 (fr) 1980-07-18
GB2113204B (en) 1984-02-01
FR2444462B1 (fr) 1986-08-29
FI794036A (fi) 1980-06-23
GB2040681A (en) 1980-09-03
ES487159A0 (es) 1980-12-16
FI66354B (fi) 1984-06-29
IL59019A (en) 1984-05-31
NO794249L (no) 1980-06-24
GB2040681B (en) 1983-04-13
GR68018B (fi) 1981-10-27
IL59019A0 (en) 1980-03-31
NZ192453A (en) 1982-09-07
ZW25379A1 (en) 1981-07-22
AU566013B2 (en) 1987-10-08
AU532332B2 (en) 1983-09-29
CH647236A5 (de) 1985-01-15
PT70624A (en) 1980-01-01
SE7910612L (sv) 1980-06-23
AU1640083A (en) 1983-11-17
AT373878B (de) 1984-02-27
HU183013B (en) 1984-04-28
FI66354C (fi) 1984-10-10
CA1127651A (en) 1982-07-13
FR2445321A1 (fi) 1980-07-25
YU314979A (en) 1983-02-28
DK548179A (da) 1980-06-23
ES8101558A1 (es) 1980-12-16
DE2951213A1 (de) 1980-07-10
GB2113204A (en) 1983-08-03
ATA808979A (de) 1983-07-15
IT1126839B (it) 1986-05-21
PH16571A (en) 1983-11-18

Similar Documents

Publication Publication Date Title
US4057636A (en) Antihypertensive pyridylguanidine compounds
SU1349700A3 (ru) Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами
CZ282142B6 (cs) Cykloalkylsubstituované glutaramidové deriváty, farmaceutický prostředek obsahující tyto sloučeniny a použití
CZ62699A3 (cs) Heterocyklické inhibitory metaloproteinas
US3803324A (en) Amino-guanidine derivatives useful for regulating blood pressure
EP0029663B1 (en) N-aryl-n'-imidazol-2-ylureas, process for their preparation and pharmaceutical compositions containing them
EA008249B1 (ru) Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств
US4239768A (en) Method for relieving irritable bowel syndrome symptoms
US5166162A (en) Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
NL7909265A (nl) N-aryl-n'-(2-imidazolidinylideen)-ureumderivaten, alsmede farmaceutische preparaten, die deze derivaten bevatten.
US20040039045A1 (en) (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists
DE2531829C2 (de) N-(3,4,5-Trimethoxycinnamoyl)-N'- (2'-pyrrolidinon-1'-carbonylmethyl) -piperazin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
US4668683A (en) Cardiotonic quinazoline derivatives
US4229462A (en) Method for controlling hypertension and compositions
RU2404974C2 (ru) БРОМИД 1-(β-ФЕНИЛЭТИЛ)-4-АМИНО-1,2,4-ТРИАЗОЛИЯ (МТ), ОБЛАДАЮЩИЙ КАРДИОПРОТЕКТИВНЫМ, ПРОТИВОИШЕМИЧЕСКИМ, АНТИГИПЕРТЕНЗИВНЫМ, АНТИОКСИДАНТНЫМ, ПРОТЕИНСИНТЕТИЧЕСКИМ И ЭНЕРГОТРОПНЫМ ДЕЙСТВИЕМ
GB2149395A (en) Amidines derived from 4-phenyl-2-substituted imidazoles
JP2798628B2 (ja) 癲癇治療用の５−アミノカルボニル−５Ｈ−ジベンゾ［ａ，ｄ］シクロヘプテン−５，１０−イミン
EA004042B1 (ru) Новые соединения аминопирролина, способ их получения и содержащие их фармацевтические композиции
JPS5976083A (ja) ジヒドロピリジン類
US4298746A (en) N-(Substituted phenyl)-N'-(2-imidazolidinylidene)ureas
JPH02167277A (ja) 新規なジアジン化合物
US4507304A (en) Use of 6-amino-5-pyrimidinecarbonitrile derivatives as cardiotonic agents
KR840001709B1 (ko) N-아릴-n'-[(1, 4, 5, 6-테트라히드로피리미딘-2-일)및 (4, 5, 6, 7-테트라히드로-1-h-1, 3-디아제핀-2-일))우레아의 제조방법
GB2094300A (en) 4-(5)-alkylmercaptoimidazole derivatives, a process for their production and medicaments containing these compounds
JPS634556B2 (fi)

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed